CannaRoyalty Shares Closing Details of Anandia Acquisition

- August 9th, 2018

CannaRoyalty announced the closing of the C$115 million acquisition of its subsidiary Anandia Laboratories by Aurora Cannabis.

CannaRoyalty (CSE:CRZ) announced the closing of the C$115 million acquisition of its subsidiary Anandia Laboratories by Aurora Cannabis (TSX:ACB).

As quoted in the press release:

Under CannaRoyalty’s formerly disclosed investment relationship with Anandia, CannaRoyalty initially invested approximately C$4 million in Anandia, in February 2017. With the close of the Acquisition, CannaRoyalty’s equity stake in Anandia is valued at approximately C$17 million based on the closing price of Aurora shares on August 8, 2018, representing a return on investment of approximately 315 [percent] for the Company’s shareholders.

Pursuant to the acquisition agreement signed by Anandia and Aurora, Aurora purchased 100 [percent] of the issued and outstanding shares from Anandia’s shareholders in exchange for common shares of Aurora based on the 20-day VWAP (to the Effective Date) equivalent to approximately C$115 million. In addition, each Aurora share was accompanied with a warrant exercisable for 1/2 of an Aurora common share at an exercise price equal to the issue price plus 10 [percent] with a term of 5 years.

Click here to read the full press release.

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time

Tags

Leave a Reply

Your email address will not be published. Required fields are marked *